FLT3 and acute myeloid leukemia: Moreover, a recent study conducted in 2021 revealed the clonal evolution of AML with FLT3-ITD mutation under treatment with midostaurin, showcasing the dynamic nature of FLT3 mutations and their potential implications for treatment response [7].